102 related articles for article (PubMed ID: 16204468)
1. Investigation of cooperativity in the binding of ligands to the D(2) dopamine receptor.
Vivo M; Lin H; Strange PG
Mol Pharmacol; 2006 Jan; 69(1):226-35. PubMed ID: 16204468
[TBL] [Abstract][Full Text] [Related]
2. Antagonist-radioligand binding to D2L-receptors in intact cells.
Packeu A; De Backer JP; Van Liefde I; Vanderheyden PM; Vauquelin G
Biochem Pharmacol; 2008 Jun; 75(11):2192-203. PubMed ID: 18436192
[TBL] [Abstract][Full Text] [Related]
3. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
Seeman P; Tallerico T; Ko F
Synapse; 2003 Sep; 49(4):209-15. PubMed ID: 12827639
[TBL] [Abstract][Full Text] [Related]
4. Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics.
Kara E; Lin H; Strange PG
J Neurochem; 2010 Mar; 112(6):1442-53. PubMed ID: 20050980
[TBL] [Abstract][Full Text] [Related]
5. Non-competitive interaction between raclopride and spiperone on human D-receptors in intact Chinese hamster ovary cells.
Packeu A; De Backer JP; Vauquelin G
Fundam Clin Pharmacol; 2010 Jun; 24(3):283-91. PubMed ID: 19909349
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor dimer formation: evidence from ligand binding.
Armstrong D; Strange PG
J Biol Chem; 2001 Jun; 276(25):22621-9. PubMed ID: 11278324
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.
Lan H; Durand CJ; Teeter MM; Neve KA
Mol Pharmacol; 2006 Jan; 69(1):185-94. PubMed ID: 16236817
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study.
Amenta F; Bronzetti E; Felici L; Ricci A; Tayebati SK
J Auton Pharmacol; 1999 Jun; 19(3):151-9. PubMed ID: 10511471
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
McCormick PN; Kapur S; Seeman P; Wilson AA
Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.
Roberts DJ; Lin H; Strange PG
Biochem Pharmacol; 2004 May; 67(9):1657-65. PubMed ID: 15081865
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of the dopamine D4 receptor in the mouse brain.
Defagot MC; Falzone TL; Low MJ; Grandy DK; Rubinstein M; Antonelli MC
J Neurosci Res; 2000 Jan; 59(2):202-8. PubMed ID: 10650878
[TBL] [Abstract][Full Text] [Related]
12. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
Cumming P; Wong DF; Gillings N; Hilton J; Scheffel U; Gjedde A
J Cereb Blood Flow Metab; 2002 May; 22(5):596-604. PubMed ID: 11973432
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and binding properties of several new dopaminergic ligands.
Tuce Z; Soskić V; Joksimović J
Drug Des Discov; 1994 Jun; 11(4):251-8. PubMed ID: 7727678
[TBL] [Abstract][Full Text] [Related]
14. Regulation of D2 dopamine receptors by amiloride and amiloride analogs.
Hoare SR; Strange PG
Mol Pharmacol; 1996 Nov; 50(5):1295-308. PubMed ID: 8913361
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inverse agonist action at D2 dopamine receptors.
Roberts DJ; Strange PG
Br J Pharmacol; 2005 May; 145(1):34-42. PubMed ID: 15735658
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of [3H]nemonapride and [3H]spiperone binding on human dopamine D4 receptors.
Hidaka K; Matsumoto M; Tada S; Tasaki Y; Yamaguchi T
Neurosci Lett; 1995 Feb; 186(2-3):145-8. PubMed ID: 7777184
[TBL] [Abstract][Full Text] [Related]
17. Antagonist-D2S-dopamine receptor interactions in intact recombinant Chinese hamster ovary cells [corrected].
Packeu A; Béghin T; De Backer JP; Vauquelin G
Fundam Clin Pharmacol; 2010 Jun; 24(3):293-303. PubMed ID: 20015228
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
19. [3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions.
Vile JM; D'Souza UM; Strange PG
J Neurochem; 1995 Feb; 64(2):940-3. PubMed ID: 7830089
[TBL] [Abstract][Full Text] [Related]
20. (-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors.
Castelli MP; Mocci I; Sanna AM; Gessa GL; Pani L
Eur J Pharmacol; 2001 Dec; 432(2-3):143-7. PubMed ID: 11740949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
